Browse resources that help your practice acquire and use XIAFLEX®
*Based on commercial insurance verification of >16,000 patient claims during the period of 5/1/19–6/11/20. Medicare Part B coverage claim based on CMA Medicare Policy Manual section 50 (Rev. 1, 10-01-03). Coverage does not equate to individual patient's out-of-pocket costs.
†Based on analysis of claims filed September 2011 through March 2018.
References: 1. Data on file. DOF-XDC-38. Endo Pharmaceuticals Inc; July 16, 2020. 2. Data on file. DOF-XDC-29. Endo Pharmaceuticals Inc; April 25, 2018.